Is inheritable genetic modification the new dividing line?

The Ethics of Inheritable Genetic Modification: A Dividing Line?

Volumn , Issue , 2006, Pages 1-16

  Rasko, John E J ^a   O’Sullivan, Gabrielle M ^b   Ankeny, Rachel A ^c  

^a University of Sydney   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927003139     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511584275.002     Document Type: Chapter

References (26)

1. J.A. Wolff and Joshua Lederberg, An early history of gene transfer and therapy, Human Gene Therapy 5 (1994), 469–80.
2. Colin F. Macilwain, World leaders heap praise on human genome landmark, Nature 405 (2000), 983–6.
3. Theodore Friedmann, The Development of Human Gene Therapy. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press (1999)
4. Angel Cid-Arregui and Alejandro Garcia Carranca, Viral Vectors: Basic Science and Gene Therapy. Natick, MA: Eaton Publishing (2000)
5. Thomas F. Kresina, An Introduction to Molecular Medicine and Gene Therapy. New York: Wiley-Liss (2001).
6. K.E. Mercola and M.J. Cline, Sounding boards: the potentials of inserting new genetic information, New England Journal of Medicine 303 (1980), 1297–300.
7. M. Edelstein, The Journal of Gene Medicine Clinical Trial Site, www.wiley.co.uk/genmed/clinical/(last accessed 31 March 2005).
8. Sue Pearson, Hepeng Jia and Keiko Kandachi, China approves first gene therapy, Nature Biotechnology 22 (2004), 3–4.
9. Erika Check, Sanctions agreed over teenager’s gene–therapy death, Nature 433 (2005), 674.
10. W. French Anderson, Gene therapy: the best of times, the worst of times, Science 288 (2000), 627–9.
11. Marina Cavazzana-Calvo, Salima Hacein-Bey, Geneviève de Saint Basile, et al., Gene therapy of human severe combined immunodeficiency (SCID)–X1 disease, Science288 (2000), 669–72.
12. S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, et al., LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID–X1, Science 302 (2003), 415–9
13. Donald B. Kohn, Michael Sadelain and Joseph C. Glorioso, Occurrence of leukaemia following gene therapy of X-linked SCID, Nature Reviews Cancer 3 (2003), 477–88
14. Jason A. Barritt, Carol A. Brenner, Henry E. Malter, et al., Mitochondria in human offspring derived from ooplasmic transplantation, Human Reproduction 16 (2001), 513–6
15. Jason A. Barritt, Carol A. Brenner, Henry E. Malter, et al., Rebuttal: interooplasmic transfers in humans, Reproductive Biomedicine Online 3 (2001), 47–8.
16. Friderun Ankel-Simons and Jim M. Cummins, Misconceptions about mitochondria and mammalian fertilization: implications for theories on human evolution, Proceedings of the National Academy of Sciences USA 93 (1996), 13859–63.
17. Paul D. Olivo, Michael J. Van de Walle, Philip J. Laipis, et al., Nucleotide sequence evidence for rapid genotypic shifts in the bovine mitochondrial DNA D-loop, Nature 306 (1983), 400–2.
18. Audrey R. Chapman and Mark S. Frankel, Framing the issues. In: Audrey R. Chapman and Mark S. Frankel (eds.), Designing Our Descendents: The Promises and Perils of Genetic Modification. Baltimore, MD: John Hopkins University Press (2003), pp. 5–6
19. The President’s Enquiry on Bioethics, Human Cloning and Human Dignity: An Ethical Enquiry. Washington, DC (July 2002), p. xviii.
20. Allen Buchanan, Dan W. Brock, Norman Daniels, et al., From Chance to Choice: Genetics and Justice. Cambridge: Cambridge University Press (2000), p. 83
21. Ray Moseley, Commentary: maintaining the somatic/germ-line distinction: some ethical drawbacks, Journal of Medicine and Philosophy 16 (1991), 641–7.
22. Sheldon Krimsky, Human gene therapy: must we know where to stop before we start? Human Gene Therapy 1 (1990), 171–3.
23. Jason S. Robert and Françoise Baylis, Crossing species boundaries, The American Journal of Bioethics 3 (2003), 1–13.
24. Emily Marden and Dorothy Nelkin, Displaced agendas: current regulatory strategies for germ-line gene therapy, McGill Law Journal 45 (2000), 461–81,461.
25. Katherine A. High, The risks of germ-line gene transfer, Hastings Center Report 33 (2003), 3.
26. Eric M. Meslin, The President’s Council: fair and balanced? The Hastings Center Report 34 (2004), 6–8